1. |
「Predictive Factors for Efficacy of Oral Tacrolimus Induction Therapy in Moderate to Severe Ulcerative Colitis Patients: Large Multicenter Retrospective Cohort Study」
Oshima N, Hiraoka S, Hayashi R, Takahashi S, Ishii M, Hashimoto S, Yashima K, Igawa S, Inokuchi T, Ueno Y, Inaba T, Matsumoto H, Kawashima K, Takami T, Isomoto H, Shiotani A, Tanaka S, Ishihara S.
Inflammatory Bowel Diseases
2023年
8月
|
2. |
「Comparison of dapagliflozin and teneligliptin in nonalcoholic fatty liver disease patients without type 2 diabetes mellitus: a prospective randomized study」
Tobita H, Yazaki T, Kataoka M, Kotani S, Oka A, Mishiro T, Oshima N, Kawashima K, Ishimura N, Naora K, Sato S, Ishihara S.
J Clin Biochem Nutr
vol.:68
No.:2
173-180頁
2021年
4月
|
3. |
「Differential gene expression analysis of dasatinib-induced colitis in a patient with chronic myeloid leukemia followed for 3 years: a case report」
Oshima N, Mishima Y, Shibagaki K, Kawashima K, Ishimura N, Ikejiri F, Onishi C, Okada T, Inoue M, Moriyama I, Suzumiya J, Kinoshita Y, Ishihara S
BMC Gastroenterology
vol.:21
2021年
1月
ISSN:1471230X
|
4. |
「Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's Disease: A Case Report」
Kishimoto K, Kawashima K, Fukunaga M, Kotani S, Sonoyama H, Oka A, Mishima Y, Oshima N, Ishimura N, Ishikawa N, Maruyama R, Ishihara S
Internal Medicine
vol.:60
No.:3
385-389頁
2021年
2月
|
5. |
「Intestinal-type gastric dysplasia in Helicobacter pylori-naïve patients」
Shibagaki K, Itawaki A, Miyaoka Y, Kishimoto K, Takahashi Y, Kotani S, Mishiro T, Oshima N, Kawashima K, Ishimura N, Onuma H, Nagasaki M, Nagase M, Araki A, Kadota K, Kushima R, Ishihara S
Virchows Arch
vol.:480
No.:4
783-792頁
2021年
11月
|
6. |
「Primary Extragastrointestinal Stromal Tumor of Greater Omentum with Intraperitoneal Bleeding」
Kataoka M, Saitoh T, Kawashima K, Yazaki T, Sonoyama H, Okimoto E, Oka A, Mishima Y, Mishiro T, Oshima N, Shibagaki K, Tobita H, Moriyama I, Ishimura N, Nagase M, Hirahara N, Tajima Y, Ishihara S
Internal Medicine
vol.:60
No.:21
3413-3419頁
2021年
11月
|
7. |
「The Simultaneous Onset of Pancreatitis and Colitis as Immune-related Adverse Events in a Patient Receiving Nivolumab Treatment for Renal Cell Carcinoma」
Yazaki T, Moriyama I, Tobita H, Sonoyama H, Okimoto E, Oka A, Mishima Y, Oshima N, Shibagaki K, Kawashima K, Ishimura N, Nagami T, Maruyama R, Shiina H, Ishihara S
Internal Medicine
vol.:61
No.:10
1485-1490頁
2021年
11月
|